Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity

Cancer Research - United States
doi 10.1158/0008-5472.can-18-0981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cancer Vaccines: The Molecular Basis for T Cell Killing of Tumor Cells

Oncologist
Cancer ResearchMedicineOncology
1997English

Tumor Necrosis Factor-Α-Induced Cell Killing and Activation of Transcription Factor NF-κB Are Uncoupled in L929 Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Killing the Tumor Cells by Meghamite Nanoparticles

International Journal for Research in Applied Science and Engineering Technology
2017English

Cross Talk Between Peritoneal Macrophages and B-1 Cells in Vitro

PLoS ONE
Multidisciplinary
2013English

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Journal of Immunology
AllergyImmunology
2007English

Follicular Dendritic Cell Activation by TLR Ligands Promotes Autoreactive B Cell Responses

Immunity
Infectious DiseasesAllergyImmunology
2017English

The Interaction Between CD300a and Phosphatidylserine Inhibits Tumor Cell Killing by NK Cells

European Journal of Immunology
AllergyImmunology
2013English

Mebendazole Stimulates CD14+ Myeloid Cells to Enhance T-Cell Activation and Tumour Cell Killing

Oncotarget
Oncology
2018English

The Reversible Formation of Cysteine Sulfenic Acid Promotes B-Cell Activation and Proliferation

European Journal of Immunology
AllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy